bromodeoxyuridine has been researched along with Astrocytoma in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (44.68) | 18.7374 |
1990's | 19 (40.43) | 18.2507 |
2000's | 5 (10.64) | 29.6817 |
2010's | 2 (4.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grajkowska, W; Jozwiak, S; Kaminska, B; Kotulska, K; Kucharska, J; Mieczkowski, J; Pokarowski, P; Roszkowski, M; Tyburczy, ME | 1 |
Agarwal, A; Bittner, P; Dahiya, S; Joshi, N; Leonard, JR; Piwnica-Worms, D; Smith, E; Taylor, S; Weber, J; Xu, Z | 1 |
Brown, EM; Chattopadhyay, N; Godbole, MM; T-Felt Hansen, J | 1 |
Buckner, JC; Cascino, TL; Curran, WJ; Davis, R; Greenberg, HS; Gutin, P; Phillips, T; Prados, MD; Sandler, HM; Schultz, C; Seiferheld, W; Urtasun, R | 1 |
Davis, RL; Gutin, PH; Lamborn, K; Levin, VA; Phillips, TL; Prados, MR; Wara, WM; Wilson, CB | 1 |
Chandler, KL; Davis, RL; Hoshino, T; Ito, S; Lamborn, K; Malec, MK; Prados, MD; Wilson, CB; Wynne, J | 1 |
Kurihara, H; Ono, N; Tamura, M; Zama, A | 1 |
Ahn, D; Hoshino, T; Lamborn, K; Prados, MD; Wilson, CB | 1 |
Dinda, AK; Karak, AK; Kharbanda, K; Mathur, M; Roy, S; Sarkar, C | 1 |
Costa, LG; Guizzetti, M | 1 |
Battermann, JJ; Jansen, GH; Rutgers, DH; Struikmans, H; Tulleken, CA; van der Tweel, I | 1 |
Asbell, S; Comis, R; Curran, W; Davis, RL; Lamborn, K; Levin, VA; Murray, K; Nelson, J; Phillips, TL; Prados, MD; Rotman, M; Rubin, P; Sause, W; Scott, CB | 1 |
Karak, AK; Mehta, VS; Sarkar, C; Schmitt, HP; Sharma, S; Singh, R | 1 |
Feldkamp, MM; Guha, A; Lau, N | 1 |
Yung, WK | 1 |
Buckner, JC; Cascino, TL; Curran, WJ; Davis, R; Greenberg, HS; Gutin, P; Phillips, T; Prados, MD; Sandler, H; Schultz, C; Scott, C; Urtasun, R | 1 |
Flaman, JM; Foltz, G; Hieter, P; Irvin, DK; Jarell, AD; Kanning, K; Kinoshita, Y; Kornblum, HI; Morrison, RS; Nelson, PS; Schuster, J; Sopher, BL | 1 |
Bergström, M; Fasth, KJ; Gudjonssona, O; Kristjansson, S; Långström, B; Nyberg, G; Wu, F | 1 |
Adamczyk, A; Gasińska, A; Krzyszk wski, T; Niemiec, J; Skołyszewski, J | 1 |
Isoe, S; Kawaoi, A; Kimura, R; Naganuma, H; Nakano, S; Nukui, H; Sasaki, A; Suzuki, K | 1 |
Davis, RL; Edwards, MS; Hoshino, T; Ito, S; Prados, MD; Shibuya, M | 1 |
Asai, A; Hoshino, T; Ito, S; Krouwer, HG; McDermott, MW; Prados, MD | 1 |
Batorski, L; Daumas-Duport, C; Hoshino, T; Labrousse, F | 1 |
Abiko, S; Aoki, H; Ito, H; Nishizaki, T; Orita, T | 1 |
Aritake, K; Asai, A; Fujimaki, T; Fukushima, T; Funada, N; Houjo, S; Koike, M; Matsutani, M; Nakamura, O; Segawa, H | 1 |
Chandler, WF; Diaz, RF; Ensminger, WD; Gebarski, SS; Hegarty, TJ; Hood, TW; Junck, L; Page, MA; Stetson, PL; Thornton, AF | 1 |
Hirakawa, K; Houri, T; Ibayashi, N; Nakamura, K; Suzuki, K | 1 |
Bigner, DD; Boyd, JC; Collins, VP; Donoso, LA; Friedman, HS; Herman, MM; Ibayashi, N; Rubinstein, LJ | 1 |
Aoki, H; Furutani, Y; Ikeyama, Y; Nishizaki, T; Orita, T; Sasaki, K | 1 |
Cho, KG; Davis, RL; Hoshino, T; Lee, KS; Prados, M; Wilson, CB | 1 |
Cho, KG; Davis, RL; Donegan, J; Hoshino, T; Nagashima, T; Slusarz, M; Wilson, CB | 1 |
Ellis, CN; Greenberg, HS; Hegarty, TJ; McCuaig, CC; Page, MA | 1 |
Collins, J; Glatstein, E; Jackson, D; Katz, D; Kinsella, T; Kornblith, P; Main, D; Rowland, J; Wright, D | 1 |
Hayakawa, T; Mogami, H; Yoshimine, T | 1 |
DeArmond, SJ; Hoshino, T; Murovic, J; Nagashima, T | 1 |
Hoshino, T; Levin, EM; Levin, VA; Murovic, J; Nagashima, T; Rupp, SM | 1 |
Davis, RL; Edwards, MS; Hoshino, T; Murovic, JA; Nagashima, T | 1 |
Chandler, WF; Diaz, RF; Ensminger, WD; Gebarski, SS; Greenberg, HS; Hood, TW; Junck, L; McKeever, P; Page, MA; Stetson, PL | 1 |
Cho, KG; Davis, RL; Edwards, MS; Hoshino, T; Lee, KS; Levin, VA; Rodriguez, LA; Wilson, CB | 1 |
Averill, DR; Chandler, WF; Diaz, RF; Ensminger, WD; Gebarski, SS; Greenberg, HS; Lichter, AS | 1 |
Hoshino, T | 2 |
Davis, RL; DeArmond, SJ; Edwards, MS; Gutin, PH; Hoshino, T; Murovic, JA; Nagashima, T; Wilson, CB | 1 |
Bektemirov, TA; Bykovsky, AF; Ilyin, KV; Irlin, IS; Mazurenko, NP; Soloviev, VD; Yershov, FI; Zhdanov, VM | 1 |
Hoshino, T; Nagai, M; Sano, K | 1 |
Cheung, NH; Marks, A; Schimmer, BP; Stevenson, LF; ter Hofstede, C | 1 |
Ishimori, S; Kagawa, M; Kanno, T; Moriyama, M; To, T | 1 |
1 review(s) available for bromodeoxyuridine and Astrocytoma
Article | Year |
---|---|
Proliferative potential of pediatric brain tumors.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Female; Glioma; Humans; Male; Meningioma; Teratoma | 1987 |
6 trial(s) available for bromodeoxyuridine and Astrocytoma
Article | Year |
---|---|
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Chemotherapy, Adjuvant; Female; Humans; Lomustine; Male; Middle Aged; Procarbazine; Radiation-Sensitizing Agents; Vincristine | 2004 |
Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Disease-Free Survival; Glioblastoma; Humans; Lomustine; Middle Aged; Procarbazine; Vincristine | 1995 |
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Chemotherapy, Adjuvant; Disease Progression; Female; Humans; Lomustine; Male; Middle Aged; Procarbazine; Proportional Hazards Models; Radiation-Sensitizing Agents; Survival Analysis; Vincristine | 1999 |
Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Clinical Trials as Topic; Combined Modality Therapy; Female; Glioblastoma; Humans; Infusion Pumps; Infusions, Intra-Arterial; Male; Middle Aged; Radiation-Sensitizing Agents; Survival Analysis; United States | 1990 |
Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme.
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Drug Evaluation; Female; Glioblastoma; Humans; Idoxuridine; Infusions, Intravenous; Male; Middle Aged; Prognosis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Subclavian Vein; Time Factors | 1987 |
Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Clinical Trials as Topic; Humans; Infusions, Intra-Arterial; Middle Aged; Mortality; Neoplasm Recurrence, Local; Radiation Injuries; Radiation-Sensitizing Agents; Time Factors; Tomography, X-Ray Computed; Veins | 1988 |
40 other study(ies) available for bromodeoxyuridine and Astrocytoma
Article | Year |
---|---|
Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications.
Topics: Astrocytes; Astrocytoma; Bromodeoxyuridine; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Giant Cells; Humans; Immunohistochemistry; Models, Biological; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; TOR Serine-Threonine Kinases; Tuberous Sclerosis | 2010 |
Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest.
Topics: Adolescent; Adult; Aged; Animals; Astrocytoma; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Child; Child, Preschool; Disease Models, Animal; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Glial Fibrillary Acidic Protein; Humans; Male; Mice; Middle Aged; Neoplasm Transplantation; Nuclear Proteins; Nucleolin; Phosphoproteins; RNA-Binding Proteins; RNA, Small Interfering; Xenograft Model Antitumor Assays; Young Adult | 2012 |
Transforming growth factor beta receptor family ligands inhibit hepatocyte growth factor synthesis and secretion from astrocytoma cells.
Topics: Activin Receptors; Activins; Analysis of Variance; Astrocytoma; Blotting, Northern; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bromodeoxyuridine; Cell Division; Cell Line, Tumor; Culture Media, Conditioned; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hepatocyte Growth Factor; Humans; Inhibin-beta Subunits; Ligands; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Smad Proteins; Starvation; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Proliferative potential and prognostic evaluation of low-grade astrocytomas.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Disease Progression; Female; Humans; Infant; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Survival Analysis; Tumor Cells, Cultured | 1994 |
Changes of the bromodeoxyuridine labeling index of astrocytic tumors between primary and recurrent lesions.
Topics: Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Recurrence, Local | 1994 |
Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling.
Topics: Age Factors; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Glioblastoma; Humans; Male; Prognosis; Survival Analysis | 1993 |
Morphological appearance, growth kinetics and glial fibrillary acidic protein (GFAP) expression in primary in vitro explant culture of astrocytic neoplasms.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Female; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Immunoenzyme Techniques; Male; Tumor Cells, Cultured | 1993 |
Inhibition of muscarinic receptor-stimulated glial cell proliferation by ethanol.
Topics: Acetaldehyde; Acetylcholine; Animals; Astrocytes; Astrocytoma; Bisbenzimidazole; Bromodeoxyuridine; Carbachol; Cell Division; Central Nervous System Depressants; Cerebral Cortex; Dose-Response Relationship, Drug; Ethanol; Ethidium; Female; Flow Cytometry; Humans; Mitogens; Muscarinic Agonists; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Tumor Cells, Cultured | 1996 |
S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
Topics: Aneuploidy; Antimetabolites; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Diploidy; DNA, Neoplasm; Flow Cytometry; Glioma; Humans; Meningioma; Oligodendroglioma; Ploidies; S Phase | 1997 |
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma mult
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Antineoplastic; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Female; Glioblastoma; Glioma; Humans; Karnofsky Performance Status; Male; Middle Aged; Proportional Hazards Models; Radiation-Sensitizing Agents; Regression Analysis; Retrospective Studies | 1998 |
A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Diagnosis, Computer-Assisted; Female; Glioma; Humans; Male; Neoplasm Staging; Prognosis; World Health Organization | 1999 |
Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
Topics: Alkyl and Aryl Transferases; Angiogenesis Inhibitors; Antineoplastic Agents; Apoptosis; Astrocytoma; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Bromodeoxyuridine; Cell Cycle; Cell Division; Central Nervous System Neoplasms; Dose-Response Relationship, Drug; Endothelial Growth Factors; Enzyme Inhibitors; ErbB Receptors; Farnesyltranstransferase; Genes, ras; Growth Inhibitors; Humans; Lymphokines; Membrane Proteins; Methionine; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myelin Basic Protein; Neovascularization, Pathologic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
BUdR radiosensitization in anaplastic astrocytoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Humans; Lomustine; Procarbazine; Radiation-Sensitizing Agents; Vincristine | 1999 |
Pescadillo, a novel cell cycle regulatory protein abnormally expressed in malignant cells.
Topics: Amino Acid Sequence; Animals; Astrocytes; Astrocytoma; Brain; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; COS Cells; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Molecular Sequence Data; Molecular Weight; Neoplasms; Proteins; RNA-Binding Proteins | 2001 |
Analysis of 76Br-BrdU in DNA of brain tumors after a PET study does not support its use as a proliferation marker.
Topics: Aged; Astrocytoma; Brain Neoplasms; Bromine Radioisotopes; Bromodeoxyuridine; DNA, Neoplasm; Female; Humans; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Radiation-Sensitizing Agents; Tomography, Emission-Computed | 2001 |
Prognostic significance of DNA ploidy and proliferation rate in human astrocytic gliomas.
Topics: Adult; Aneuploidy; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Humans; Male; Middle Aged; Multivariate Analysis; Nucleolus Organizer Region; Ploidies; Prognosis; S Phase; Silver Staining; Survival Rate | 2000 |
Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Topics: Antigens, Neoplasm; Astrocytoma; Biomarkers, Tumor; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cerebellar Neoplasms; Craniotomy; Glioblastoma; Humans; Immunoenzyme Techniques; Infusions, Intravenous; Medulloblastoma; Meningeal Neoplasms; Meningioma; Neoplasm Recurrence, Local; Neurilemmoma; Nuclear Proteins; Proliferating Cell Nuclear Antigen | 1992 |
Proliferative characteristics of juvenile pilocytic astrocytomas determined by bromodeoxyuridine labeling.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Child; Child, Preschool; Female; Humans; Immunohistochemistry; Infant; Male; Neoplasm Recurrence, Local | 1992 |
A comparison of CT contrast enhancement and BUDR labeling indices in moderately and highly anaplastic astrocytomas of the cerebral hemispheres.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Sex Factors; Tomography, X-Ray Computed | 1992 |
Histological grading and bromodeoxyuridine labeling index of astrocytomas. Comparative study in a series of 60 cases.
Topics: Adolescent; Adult; Age Factors; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child; Child, Preschool; Female; Glioblastoma; Humans; Infant; Male; Middle Aged; Regression Analysis; S Phase | 1991 |
Subependymal giant cell astrocytoma associated with tuberous sclerosis: with special reference to cell kinetic studies--case report.
Topics: Adolescent; Astrocytoma; Bromodeoxyuridine; Cell Cycle; Cerebral Ventricle Neoplasms; Ependyma; Flow Cytometry; Humans; Male; Tomography, X-Ray Computed; Tuberous Sclerosis | 1990 |
Correlation between bromodeoxyuridine-labeling indices and patient prognosis in cerebral astrocytic tumors of adults.
Topics: Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Follow-Up Studies; Glioma; Humans; Neoplasm Recurrence, Local; Prognosis; Survival Rate | 1991 |
[Immunohistochemical study of S-phase cells in human gliomas].
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child; Female; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Immunohistochemistry; Interphase; Male; Middle Aged; Staining and Labeling; Vimentin | 1988 |
Relationship of the demonstration of intermediate filament protein to kinetics of three human neuroepithelial tumor cell lines. Lack of neural-related proteins in most cells in S phase: a double-labeled immunohistochemical study on matrix cultures.
Topics: Astrocytoma; Bromodeoxyuridine; Cell Cycle; Humans; Immunoenzyme Techniques; Intermediate Filament Proteins; Interphase; Medulloblastoma; Neurofilament Proteins; Retinoblastoma; Tumor Cells, Cultured; Vimentin | 1989 |
Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors.
Topics: Aneuploidy; Antibodies, Monoclonal; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; DNA; Flow Cytometry; Glioblastoma; Humans; Immunoenzyme Techniques; Meningeal Neoplasms; Meningioma | 1989 |
Prognostic implications of the bromodeoxyuridine labeling index of human gliomas.
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Glioblastoma; Humans; Neoplasm Recurrence, Local; Prognosis; Time Factors | 1989 |
Variability in the proliferative potential of human gliomas.
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Glioblastoma; Glioma; Humans; Interphase | 1989 |
Mucocutaneous complications of intraarterial 5-bromodeoxyuridine and radiation.
Topics: Alopecia; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Conjunctivitis, Bacterial; Facial Dermatoses; Humans; Infusions, Intra-Arterial; Mouth Diseases; Nail Diseases; Radiation Dosage; Radiation-Sensitizing Agents; Radiodermatitis; Radiography; Ulcer | 1989 |
[Factors affecting the prognosis of brain tumors].
Topics: Age Factors; Antibodies, Monoclonal; Astrocytoma; Biomarkers, Tumor; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Epidermal Growth Factor; ErbB Receptors; Glioblastoma; Humans; Meningioma; Oligodendroglioma; Oncogenes; Prognosis | 1988 |
Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues.
Topics: Aged; Antibodies, Monoclonal; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child, Preschool; Female; Glioblastoma; Glioma; Histocytochemistry; Humans; Immunochemistry; Interphase; Male; Meningioma; Middle Aged | 1985 |
Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
Topics: Antibodies, Monoclonal; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Glioblastoma; Humans; Immunoenzyme Techniques; Interphase; Meningioma; Metabolic Clearance Rate | 1985 |
Pediatric central nervous system tumors: a cell kinetic study with bromodeoxyuridine.
Topics: Adolescent; Astrocytoma; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cerebellar Neoplasms; Child; Child, Preschool; DNA, Neoplasm; Female; Glioblastoma; Humans; Immunoenzyme Techniques; Infant; Male; Medulloblastoma; Prognosis | 1986 |
Prognostic implications of the proliferative potential of low-grade astrocytomas.
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Humans; Interphase; Neoplasm Recurrence, Local; Prognosis | 1988 |
Intra-arterial 5-bromo-2-deoxyuridine (BUdR) radiosensitization with external beam radiation in rhesus monkeys: toxicity study.
Topics: Animals; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Infusions, Intra-Arterial; Macaca mulatta; Magnetic Resonance Imaging; Radiation-Sensitizing Agents | 1988 |
In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; DNA; Ependymoma; Female; Glioma; Humans; Infant; Kinetics; Male; Medulloblastoma; Middle Aged | 1986 |
Isolation of oncornaviruses from continuous human cell cultures.
Topics: Amnion; Astrocytoma; Bromodeoxyuridine; Carcinoma; Cell Line; Centrifugation, Density Gradient; Dactinomycin; Female; HeLa Cells; Humans; Kidney; Laryngeal Neoplasms; Microscopy, Electron; Mitomycins; Mycoplasma; Oncogenic Viruses; Ovarian Neoplasms; Retroviridae; RNA Viruses; RNA-Directed DNA Polymerase; RNA, Viral; Sarcoma; Stomach Neoplasms; Tritium; Uridine | 1973 |
Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Culture Techniques; DNA; Floxuridine; Fluorouracil; Follow-Up Studies; Glioma; Humans; Meningioma; Methotrexate; Oligodendroglioma; Radiation-Sensitizing Agents; Thymidine | 1968 |
[Treatment of malignant brain tumors by BAR therapy].
Topics: Adolescent; Adult; Arteries; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child; Ependymoma; Female; Follow-Up Studies; Glioblastoma; Humans; Infusions, Parenteral; Male; Melanoma; Meningioma; Middle Aged; Neoplasm Metastasis; Oligodendroglioma; Papilloma | 1968 |
Glial tumor cells deficient in thymidine kinase: isolation and characterization.
Topics: Adenylyl Cyclases; Animals; Astrocytoma; Bromodeoxyuridine; Cell Line; Cells, Cultured; Clone Cells; Glucosephosphate Dehydrogenase; Hybrid Cells; In Vitro Techniques; Mutagens; Nitrosoguanidines; Rats; S100 Proteins; Thymidine Kinase | 1974 |
[Effect of BAR therapy in a case of malignant glioma with extracranial metastasis].
Topics: Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; DNA, Neoplasm; Head and Neck Neoplasms; Humans; Male; Neoplasm Metastasis; Radiation-Sensitizing Agents | 1970 |